blood clots and glp 1 GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies April 2025 PEP Talk: Weight,

Sign Up for Further Educational Material If you would like to make sure you don't miss a Blog update from me, or would like to receive more information in the form of upcoming e-Books and Online courses, then please subscribe to my mailing list at the bottom of the Blog front page

Resistance training preserves and builds lean tissue during GLP-1 treatment by creating mechanical tension and protein synthesis stimulus that counteracts the medication's appetite suppression and modest lean mass reduction

Who Its For Semaglutide is designed for adults who have struggled to lose weight through diet and exercise alone

A 2016 comparative study published in Nature Scientific Reports demonstrated that GHK-Cu produced no cytotoxicity to human keratinocytes at concentrations up to 5,800 micromolar over 72 hours and did not induce inflammatory biomarkers, unlike other copper compounds tested alongside it